Nabil M. Yazgi
Corporate Officer/Principal presso American Academy of Neurology
Profilo
Nabil M.
Yazgi is a member of the American Academy of Neurology and the Neurological Association of New Jersey.
He previously worked as a Director at Camp Nine, Inc. and Relmada Therapeutics, Inc. He also served as an Independent Class I Director at Relmada Therapeutics, Inc. from 2014 to 2015.
Dr. Yazgi earned a doctorate degree from Damascus University in 1985.
Currently, he holds positions at the American Academy of Neurology and the Neurological Association of New Jersey.
Posizioni attive di Nabil M. Yazgi
Società | Posizione | Inizio |
---|---|---|
American Academy of Neurology
American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services American Academy of Neurology operates a professional society which represents neurologists and neuroscientists. The company was founded in 1948 and is headquartered in Minneapolis, MN. | Corporate Officer/Principal | - |
Neurological Association of New Jersey | Corporate Officer/Principal | - |
Precedenti posizioni note di Nabil M. Yazgi
Società | Posizione | Fine |
---|---|---|
RELMADA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 06/11/2015 |
Relmada Therapeutics, Inc. /Old/
Relmada Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Relmada Therapeutics, Inc. is a holding company, which engages in the development of pharmaceutical drugs for the treatment of acute and chronic pains. It focuses in the developing of chronic pain due to cancer, musculoskeletal disorders, and peripheral neuropathy. The company was founded in 2000 and is headquartered in Blue Bell, PA. | Direttore/Membro del Consiglio | - |
Camp Nine, Inc.
Camp Nine, Inc. Pharmaceuticals: GenericHealth Technology Camp Nine, Inc. operates as a clinical stage biopharmaceutical company. The company through its subsidiary Relmada Therapeutics, Inc. focused on developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of pain. Camp Nine was founded on May 31, 2012 and is headquartered in New York, NY. | Direttore/Membro del Consiglio | - |
Formazione di Nabil M. Yazgi
Damascus University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
RELMADA THERAPEUTICS, INC. | Health Technology |
Aziende private | 4 |
---|---|
Camp Nine, Inc.
Camp Nine, Inc. Pharmaceuticals: GenericHealth Technology Camp Nine, Inc. operates as a clinical stage biopharmaceutical company. The company through its subsidiary Relmada Therapeutics, Inc. focused on developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of pain. Camp Nine was founded on May 31, 2012 and is headquartered in New York, NY. | Health Technology |
American Academy of Neurology
American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services American Academy of Neurology operates a professional society which represents neurologists and neuroscientists. The company was founded in 1948 and is headquartered in Minneapolis, MN. | Commercial Services |
Relmada Therapeutics, Inc. /Old/
Relmada Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Relmada Therapeutics, Inc. is a holding company, which engages in the development of pharmaceutical drugs for the treatment of acute and chronic pains. It focuses in the developing of chronic pain due to cancer, musculoskeletal disorders, and peripheral neuropathy. The company was founded in 2000 and is headquartered in Blue Bell, PA. | Health Technology |
Neurological Association of New Jersey |
- Borsa valori
- Insiders
- Nabil M. Yazgi